| Original language | English |
|---|---|
| Pages (from-to) | 414-417 |
| Number of pages | 4 |
| Journal | Canadian Journal of Cardiology |
| Volume | 38 |
| Issue number | 4 |
| Early online date | 2022 |
| DOIs | |
| Publication status | Published - Apr 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Canadian Journal of Cardiology, Vol. 38, No. 4, 04.2022, p. 414-417.
Research output: Contribution to journal › Editorial › Academic › peer-review
TY - JOUR
T1 - Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias
T2 - Pushing Sudden Death Into Overtime
AU - Sapp, John L.
AU - Krahn, Andrew
AU - Stevenson, William G.
AU - Remme, Carol Ann
AU - Philippon, Francois
AU - Nattel, Stanley
N1 - Funding Information: J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc., Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose. Funding Information: The authors have no funding sources to declare. J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 ?Method for ablating with needle electrode? patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc. Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose.
PY - 2022/4
Y1 - 2022/4
UR - http://www.scopus.com/inward/record.url?scp=85125652092&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.cjca.2022.02.013
DO - https://doi.org/10.1016/j.cjca.2022.02.013
M3 - Editorial
C2 - 35183676
SN - 0828-282X
VL - 38
SP - 414
EP - 417
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 4
ER -